retatrutide type 2 diabetes trial results 🚨Breaking: Retatrutide's first Phase 3 T2D data just dropped. ▸ A1C: −2.0% at 40 weeks ▸ Weight: −36.6 lbs (−16.8%) at 12 mg ▸ No weight loss plateau — curve still descending Retatrutide UK Guide: Key Facts

Your endocrinologist will evaluate your overall health, weight loss rate, and hormonal status to determine the appropriate course

Set reminders every 90 minutes and drink 8 ounces regardless of whether you feel thirsty

In addition to GLP-1 therapy, we offer a range of weight loss and wellness services to complement your treatment and ensure long-term success

Body-weight reduction in obesity (phase 2) A 48-week randomised, double-blind, placebo-controlled phase 2 trial in the New England Journal of Medicine studied retatrutide in 338 adults with obesity

The standard preparation is 2 mL of bacteriostatic water added to a 20 mg vial, producing a 10 mg/mL solution

What Are the Negative Side Effects of GLP-1 Drugs